English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12190/12972 (94%)
Visitors : 1060515      Online Users : 512
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    會議論文/會議摘要 [10/19]
    報告 [0/1]
    專利 [0/82]

    Collection Statistics

    近3年內發表的文件:1(0.91%)
    含全文筆數:110(100.00%)

    文件下載次數統計
    下載大於0次:110(100.00%)
    下載大於100次:110(100.00%)
    檔案下載總次數:92638(93.25%)

    最後更新時間: 2024-12-11 16:28


    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目26-50 / 110. (共5頁)
    << < 1 2 3 4 5 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2013-06 Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) Bioorganic and Medicinal Chemistry. 2013 Jun;21(11):2856-2867.
    2013-05 Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus Antiviral Research. 2013 May;98(2):228-241.
    2013-05 Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules Proceedings of the National Academy of Sciences of the United States of America. 2013 May;110(19):E1779-E1787.
    2013-05 Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors Journal of Medicinal Chemistry. 2013 May;56(10):3889-3903.
    2013-02 Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems Antimicrobial Agents and Chemotherapy. 2013 Feb; 57(2):723-733.
    2013-01 3D-QSAR-assisted drug design: Identification of a potent quinazoline-based aurora kinase inhibitor ChemMedChem. 2013 Jan;8(1):136-148.
    2012-12-13 Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: Exploration of the role of tylophorine e ring on biological activity Journal of Medicinal Chemistry. 2012 Dec 13;55(23):10363-10377.
    2012-12 An efficient, mild and scalable synthesis of bioactive compounds containing the angelicin scaffold Journal of the Chinese Chemical Society. 2012 Dec;59(12):1548-1554.
    2012-09 Anti-influenza drug discovery: Identification of an orally bioavailable quinoline derivative through activity- and property-guided lead optimization ChemMedChem. 2012 Sep;7(9):1546-1550.
    2012-09 Putative tumor metastasis-associated genes in human gastric cancer International Journal of Oncology. 2012 Sep;41(3):1068-1084.
    2012-07 Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors International Journal of Obesity. 2012 Jul;36(7):999-1006.
    2012-06-07 3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) Bioorganic and Medicinal Chemistry Letters. 2012 Jun 7;22(14):4654-4659.
    2012-06 EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells Molecular Oncology. 2012 Jun;6(3):299-310.
    2012-02 Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents Investigational New Drugs. 2012 Feb;30(1):164-175.
    2012-02 Discovery of novel stem cell mobilizers that target the CXCR4 receptor ChemMedChem. 2012 Feb;7(2):209-212.
    2012-01 Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor Antimicrobial Agents and Chemotherapy. 2012 Jan;56(1):44-53.
    2012-01 BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML British Journal of Cancer. 2012 Jan;106(3):475-481.
    2012-01 A High-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors Anticancer Research. 2012 Jan;32(1):147-151.
    2011-11 Isolation and biological activities of phenanthroindolizidine and septicine alkaloids from the formosan tylophora ovata Planta Medica. 2011 Nov;77(17):1932-1938.
    2011-09 Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway Journal of Virology. 2011 Sep;85(17):9114-9126
    2011-07-25 The first total synthesis of cytopiloyne, an anti-diabetic, polyacetylenic glucoside Chemistry-A European Journal. 2011 Jul 25;17(31):8696-8703.
    2011-07 Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) Bioorganic and Medicinal Chemistry. 2011 Jul;19(14):4173-4182 .
    2011-06 Hot topic: Opportunities and potential challenges for the treatment of metabolic syndrome Current Topics In Medicinal Chemistry. 2011 Jun;11(12):1420.
    2011-04 Isatin-beta-thiosemicarbazones as potent herpes simplex virus inhibitors Bioorganic and Medicinal Chemistry Letters. 2011 Apr;21(7):1948-1952.
    2011-03 Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes Journal of Virology. 2011 Mar;85(6):2927-2941.

    顯示項目26-50 / 110. (共5頁)
    << < 1 2 3 4 5 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋